A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Boston Scientific Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 175,902 shares of BSX stock, worth $15.3 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
175,902
Previous 116,548 50.93%
Holding current value
$15.3 Million
Previous $8.98 Million 64.23%
% of portfolio
0.08%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $4.33 Million - $4.99 Million
59,354 Added 50.93%
175,902 $14.7 Million
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $445,993 - $514,751
-6,624 Reduced 5.38%
116,548 $8.98 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $7.09 Million - $8.45 Million
123,172 New
123,172 $8.37 Billion
Q4 2023

Aug 14, 2024

BUY
$48.64 - $57.81 $91,394 - $108,624
1,879 Added 3.41%
56,935 $3.29 Billion
Q3 2023

Aug 14, 2024

SELL
$50.19 - $54.68 $34,781 - $37,893
-693 Reduced 1.24%
55,056 $2.91 Billion
Q2 2023

Aug 14, 2024

BUY
$49.72 - $54.64 $241,340 - $265,222
4,854 Added 9.54%
55,749 $3.02 Billion
Q1 2023

Aug 14, 2024

SELL
$45.09 - $50.03 $356,752 - $395,837
-7,912 Reduced 13.45%
50,895 $2.55 Billion
Q4 2022

Aug 14, 2024

SELL
$39.56 - $47.22 $12,817 - $15,299
-324 Reduced 0.55%
58,807 $2.72 Billion
Q3 2022

Aug 14, 2024

SELL
$36.71 - $109.66 $64,022 - $191,247
-1,744 Reduced 2.86%
59,131 $2.29 Billion
Q2 2022

Aug 14, 2024

SELL
$35.24 - $47.1 $243,156 - $324,990
-6,900 Reduced 10.18%
60,875 $2.27 Billion
Q1 2022

Aug 14, 2024

SELL
$40.9 - $45.1 $1.99 Million - $2.2 Million
-48,773 Reduced 41.85%
67,775 $3 Billion
Q4 2021

Aug 30, 2024

SELL
$38.07 - $44.87 $226,630 - $267,111
-5,953 Reduced 3.88%
147,637 $6.27 Billion
Q3 2021

Aug 30, 2024

BUY
$41.23 - $45.88 $46,260 - $51,477
1,122 Added 0.74%
153,590 $6.66 Billion
Q2 2021

Aug 30, 2024

BUY
$38.58 - $44.24 $1.39 Million - $1.59 Million
35,920 Added 30.82%
152,468 $6.52 Billion
Q1 2021

Aug 30, 2024

SELL
$35.27 - $39.67 $415,586 - $467,431
-11,783 Reduced 7.9%
137,445 $5.31 Billion
Q4 2020

Aug 30, 2024

BUY
$33.15 - $41.97 $487,934 - $617,756
14,719 Added 10.94%
149,228 $5.36 Billion
Q3 2020

Aug 30, 2024

BUY
$34.44 - $42.23 $2.93 Million - $3.59 Million
85,111 Added 172.3%
134,509 $5.14 Billion
Q2 2020

Aug 30, 2024

BUY
$30.19 - $39.11 $26,174 - $33,908
867 Added 1.79%
49,398 $1.73 Billion
Q1 2020

Aug 30, 2024

BUY
$25.83 - $45.71 $355,214 - $628,603
13,752 Added 39.54%
48,531 $1.58 Billion
Q4 2019

Aug 30, 2024

BUY
$37.87 - $45.37 $19,010 - $22,775
502 Added 1.46%
34,779 $1.57 Billion
Q3 2019

Aug 30, 2024

SELL
$40.31 - $43.45 $17,172 - $18,509
-426 Reduced 1.23%
34,277 $1.39 Billion
Q2 2019

Aug 30, 2024

BUY
$34.91 - $42.98 $1.14 Million - $1.41 Million
32,784 Added 1708.39%
34,703 $1.49 Billion
Q1 2019

Aug 30, 2024

SELL
$32.91 - $40.75 $42,782 - $52,975
-1,300 Reduced 40.39%
1,919 $73.7 Million
Q4 2018

Aug 30, 2024

SELL
$31.73 - $39.04 $3.6 Million - $4.42 Million
-113,329 Reduced 97.24%
3,219 $114 Million
Q2 2018

Aug 30, 2024

SELL
$26.84 - $34.32 $3,140 - $4,015
-117 Reduced 6.18%
1,775 $58 Million
Q1 2018

Aug 30, 2024

SELL
$25.2 - $28.54 $7,056 - $7,991
-280 Reduced 12.89%
1,892 $51.7 Million
Q4 2017

Aug 30, 2024

BUY
$24.79 - $29.8 $3,396 - $4,082
137 Added 6.73%
2,172 $53.8 Million
Q3 2017

Aug 30, 2024

SELL
$26.26 - $29.17 $8,928 - $9,917
-340 Reduced 14.32%
2,035 $59.4 Million
Q2 2017

Aug 30, 2024

SELL
N/A
-945 Reduced 28.46%
2,375 $65.8 Million
Q1 2017

Aug 30, 2024

SELL
N/A
-113,228
3,320 $82.6 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.